Monday, 22 January 2018

Celgene to buy Juno for $9 billion to boost CAR-T expertise

(Reuters) - Celgene Corp announced a $9 billion cash buyout of Juno Therapeutics Inc on Monday as it moves to cement its position as a key player in a new range of cancer therapies.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)